Navigation Links
Cryo-Cell International’s New 5-Chamber Cord Blood Cryo-Bag Gives Parents Multiple Treatment Options
Date:4/7/2017

Cryo-Cell International has launched a new forward-looking, five-chamber cord blood freezer bag, which will give parents and doctors the opportunity to use the baby’s stored cord blood stem cells multiple times.

“This is another example of Cryo-Cell leading the industry to ensure that we offer parents the highest quality cord blood stem cell collection,” said David Portnoy, Cryo-Cell International’s Chairman and Co-CEO.

Parents know that their baby’s cord blood stem cells are precious. They know that they can be used not only by the baby but also by other immediate family members and that they are currently employed in the treatment of nearly 80 diseases. Parents may have concerns of using their baby’s cord blood stem cells for a non-life-threatening condition or in a yet-unproven clinical trial in fear that they will deplete their stem cell supply.

The new five-chamber bag from Cryo-Cell International will give families the option to use some of their stem cells for one clinical application and still retain more stem cells for future use. In addition, the new cord blood freezer bag is being introduced along with other internal, proprietary process improvements that have increased post-thaw stem cell viability by up to 10 percent.

The five-chamber cryo-bag replaces the dual-chambered cord blood bag, which gained wide usage in the industry after it was developed in 2002. The dual-chambered bag held 80 percent of its contents in one main compartment, giving parents and doctors a 20 mL sample for transfusions and a 5 mL sample to retain for future use. The new cord blood freezer bag features five chambers, giving doctors the opportunity to utilize only a portion of the collection if desired.

The forward-looking design opens the door for future advancements in the expansion of stem cells. If the day comes when such practices have been firmly established, this new multi-chamber cryo-preservation bag will provide researchers, doctors, and families the possibility to extend usage of the stored cord blood. This may make families more receptive to clinical trials knowing that they will not have to use the entirety of their babies’ cord blood collections, which, in turn, can greatly expand the use of cord blood stem cells in the research of disease treatment.

About Cryo-Cell International, Inc.
Founded in 1989, Cryo-Cell International, Inc. is the world's first private cord blood bank. More than 500,000 parents from 87 countries trust Cryo-Cell to preserve their family members' stem cells. Cryo-Cell's mission is to provide clients with state-of-the-art stem cell cryopreservation services and support the advancement of regenerative medicine. Cryo-Cell operates in a facility that is FDA registered, cGMP-/cGTP-compliant and is licensed in all states requiring licensure. Besides being AABB accredited as a cord blood facility, Cryo-Cell is also the first U.S. (for private use only) cord blood bank to receive FACT accreditation for adhering to the most stringent cord blood quality standards set by any internationally recognized, independent accrediting organization. In addition, Cryo-Cell is ISO 9001:2008 certified by BSI, an internationally recognized, quality assessment organization. Cryo-Cell is a publicly traded company, OTCQB:CCEL. For more information, please visit http://www.cryo-cell.com. For a complete list of reference, visit http://www.cryo-cell.com/references.

Read the full story at http://www.prweb.com/releases/2017/04/prweb14222403.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related medicine news :

1. Cryo-Cell Provides Funding for Cord Blood Clinical Trial Application to Treat ALS
2. Cryo-Cell International Announces New Advanced Stem Cell Collection Kit That Every Expectant Parent Should Know About
3. New Products Announced at Jusuru International’s R2E14 National Convention
4. Radio Industry Veteran Joins CRN International’s Sales Organization in Detroit
5. Octo Consulting and VP Naina Leo were Announced as Winners of 2016 AFCEA International’s Awards for Small Business of The Year & Meritorious Service Awards.
6. Revisiting Prevention of Blood Clots in Chemotherapy Patients
7. Global Blood Collection Systems Market 2012-2016: Worldwide Industry Share, Investment Trends, Growth, Size, Strategy and Forecast Research Report 2016
8. Racial difference in blood clotting warrants a closer look at heart attack medications
9. NuvaRing Lawsuit Filed by Wright & Schulte LLC After Ohio Woman Allegedly Suffered Life-Threatening NuvaRing Blood Clots, Including Bilateral Pulmonary Emboli
10. Genetic Difference in Blood Clotting Mechanism Could Explain Some of the Racial Disparity in Heart Disease
11. How to Lower Blood Sugar Naturally, 31 Page Report Revealed By Diet Recommendations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2017)... ... August 20, 2017 , ... Are you an adult ... If so, you may be interested in participating in a research study that ... research is to understand more about the relational aspects of adults who have gluten ...
(Date:8/19/2017)... (PRWEB) , ... August 19, 2017 , ... ... announced that it is the first organization with pending recognition status from the ... Prevention Program (“DPP”) via group telehealth classes and live video conferencing. , ...
(Date:8/19/2017)... ... August 19, 2017 , ... Physician Partners of America ... as an interventional pain management physician. He brings a wealth of pain management ... headaches, and significant experience in spinal cord stimulation for chronic pain. , Dr. ...
(Date:8/18/2017)... ... August 18, 2017 , ... ... specialized asset-light logistics provider of complex transport solutions for mission-critical and non-discretionary ... Unitrans International Corporation, a division of Roadrunner Transportation Systems, Inc. (NYSE: RRTS). ...
(Date:8/18/2017)... ... ... The Dawn Johnson Insurance Group, a Missouri-based insurance and financial planning firm ... for efforts to educate the local population on cancer realities while attracting donations to ... , Each day in America, roughly 4,600 new cases of cancer are diagnosed and ...
Breaking Medicine News(10 mins):
(Date:8/17/2017)... Bio-Ess Laboratories, LLC Chief Science Officer, Dr. Adam Elhofy ... data on Cell-Ess® Universal Titer Boost at the 9 th ... August 21-25.  The Bioprocessing Summit convenes more than 1,000 international bioprocess ... ... Cell-Ess ...
(Date:8/15/2017)... Diplomat Pharmacy, Inc. (NYSE: DPLO), is now ... residents. Naloxone is available without a ... pharmacy, G-3320 Beecher Road. ... Administration, is intended to block or reverse the effects ... of consciousness. The medication is often carried by first ...
(Date:8/15/2017)... N.C. , Aug. 15, 2017 AccuGenomics, ... NC , today announced that the company has ... the University of North Carolina at Chapel Hill and ... is designed to characterize and quantify HIV reservoir and ... after pharmacological intervention. The HIV Cure Center is a ...
Breaking Medicine Technology: